Company intelligence
Outcome Capital
Strategic Life Science and Healthcare Advisory and Investment Banking Led by Industry Veterans
About Outcome Capital
Outcome Capital is a highly specialized life sciences and healthcare advisory and investment banking firm, providing innovative companies with a value-added, market-aligned approach to mergers & acquisitions, partnering and corporate finance. The firm leverages its proven ‘strategy-led execution’ approach to value enhancement by assisting management teams and their boards in navigating both financial and corporate markets and implementing the best path for success. The firm’s strength stems from its multi-disciplinary, industry experts who draw from their broad relationships and a wide range of scientific, operational, strategic and transactional expertise across the value chain. Comprised of former CEOs, business development executives, venture capitalists, PhD/MD-level scientists and clinicians, and experienced commercialization experts, our team is driven to propel innovation from bench to bedside. Outcome Capital is proud of its unique culture of intellectual agility and openness, data-driven perspectives, strategic thinking, and commitment to teamwork. We are devoted to providing unmatched advisory services to our clients and share an uncompromised dedication to the life sciences and healthcare industry success. The Outcome Capital Difference - - Creating Extraordinary Outcomes. Maximizing your company’s value by bringing… - Unique Insights - In-depth Industry Experience & Networks - Personal Commitment to Clients - Exceptional Record of Success Outcome provides comprehensive strategic advisory and investment banking services in the following areas: Life Sciences - Pharma - Medical Devices - Biotech - Healthcare Services - Diagnostics - Tools and Research - Pharma services - Digital health
Verified activity
Signals from Outcome Capital
3 published signals
Presence & Recognition
Outcome Capital hosted an expert panel and networking event around facilitating M&A transactions in the MedTech Services sector last week.
Reported by Peter Meyer
Research & Knowledge
Outcome Capital published an article in a recent In Vivo article by David Feygin, PhD, MBA and Oded Ben-Joseph, PhD, MBA, together with In Vivo's Phalguni Deswal, weighing in on a shift reshaping healthcare software market dynamics.
Reported by Outcome Capital
Research & Knowledge
Outcome Capital supported the analysis by Oded Ben-Joseph and David Feygin on why AI transactions are now a strategic imperative.
Reported by David Feygin, PhD, MBA